Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators

Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators

US Patent 6838442 · Granted Jan 4, 2005

Estimated economic value: $28,812,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human iPSC-derived brain organoids and uses thereof2025
FGFR2 inhibitors for the treatment of cholangiocarcinoma2025
Methods of treating myelodysplastic syndrome2025
Methods of treating myelodysplastic syndrome2024
Treatment of cholangiocarcinoma2024
Power cable which reduces skin effect and proximity effect2024
FGFR2 inhibitors for the treatment of cholangiocarcinoma2023
Power cable which reduces skin effect and proximity effect2023
Traditional chinese medicine composition for treating interstitial pulmonary fib2021
Data conversion systems and methods2021
Data conversion systems and methods2020
Authentication of a subscribed code table user utilizing optimized code table si2019